Panbesy Sustained-Release Capsule 30 mg (Phentermine Hydrochloride)

Adult dose

Adults: Take phentermine hydrochloride 30 mg once daily before breakfast or 2 hours after breakfast. Avoid taking it late at night because it may cause insomnia. This medication should be administered for a short period (within 4 weeks). However, to reduce inappropriate use and risks, treatment with this medication may continue if the patient achieves satisfactory weight loss within the first 4 weeks (weight loss of at least 1.8 kg or weight loss considered satisfactory by both the physician and patient).

This medication should not be used in conjunction with other appetite suppressants. It is safe to use alone and for a short duration only. This medication may be associated with primary pulmonary hypertension and valvular heart disease; if symptoms such as dyspnea, chest pain, syncope, or leg edema occur, consult a physician immediately. Patients with cardiovascular disease, hypertension, hyperthyroidism, glaucoma, anxiety disorders, or a history of substance abuse should not take this medication. Pregnant women or those who may become pregnant, as well as children under 16 years of age, should not use this medication. Diabetic patients may need to adjust insulin dosage while taking this medication, so caution is required. This medication can affect the central nervous system, leading to side effects such as anxiety, insomnia, dizziness, and headache, so caution should be exercised while driving or operating machinery. Overdosage may result in severe toxicity symptoms and cardiovascular abnormalities, so if symptoms appear, seek immediate medical attention. Taking this medication with alcohol may exacerbate side effects, so it is advisable to avoid it. This medication is classified as a controlled substance and should be used strictly according to a physician's prescription and directions; misuse can lead to serious psychological dependence and societal problems. Keep out of reach of children, and consult medical personnel immediately if any adverse reactions occur during use.

• Primary pulmonary hypertension
• regurgitant heart valve disease
• palpitations
• tachycardia
• increased blood pressure
• overstimulation
• anxiety
• dizziness
• insomnia
• discomfort

This medication should be stored in a tightly closed container to protect it from air and moisture, ideally at a temperature between 1 to 30 degrees Celsius. Proper storage maintains the drug's efficacy and safety.

Appearance

A blue opaque capsule with a white sustained-release granule filling.

Package unit

28 capsules/bottle, 30 capsules/bottle, 60 capsules/bottle, 100 capsules/bottle